Ontology highlight
ABSTRACT: Background
Significant achievements in the treatment of chronic thromboembolic pulmonary hypertension (CTEPH) have provided effective therapeutic options for most patients. However, the true impact of the changed landscape of CTEPH therapies on patients' management and outcomes is poorly known. We aimed to characterize the incidence, clinical characteristics, and outcomes of CTEPH patients in the modern era of CTEPH therapies.Methods
We analyzed the data of CTEPH adults enrolled in the prospective multicenter registry.Results
We enrolled 516 patients aged 63.8 ± 15.4 years. The incidence rate of CTEPH was 3.96 per million adults per year. The group was burdened with several comorbidities. New oral anticoagulants (n = 301; 58.3%) were preferred over vitamin K
SUBMITTER: Kopec G
PROVIDER: S-EPMC8010818 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature